Article Details

Third Rock Ventures Launches Rheos Medicines with $60 Million in Series A Funding to Harness ...

Retrieved on: 2018-03-21 18:52:30

Tags for this article:

Click the tags to see associated articles and topics

Third Rock Ventures Launches Rheos Medicines with $60 Million in Series A Funding to Harness .... View article details on hiswai:

Excerpt

<div>CAMBRIDGE, Mass.--(BUSINESS WIRE)--Rheos Medicines, Inc. was launched today with $60 million in Series A financing backed by <b>Third Rock Ventures</b>, LLC. Rheos is pioneering immunometabolism as a novel approach to tune metabolic pathways in immune cells to treat disease. The company will ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up